Daiwa Securities Group Inc. increased its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 4.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 94,875 shares of the health services provider’s stock after purchasing an additional 4,038 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Cigna Group were worth $26,112,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Beacon Financial Strategies CORP purchased a new position in shares of Cigna Group during the fourth quarter valued at $28,000. Collier Financial purchased a new position in shares of Cigna Group during the third quarter valued at $34,000. Lodestone Wealth Management LLC purchased a new position in shares of Cigna Group during the fourth quarter valued at $32,000. Creative Financial Designs Inc. ADV grew its holdings in shares of Cigna Group by 147.3% during the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after buying an additional 81 shares in the last quarter. Finally, Activest Wealth Management grew its holdings in shares of Cigna Group by 1,050.0% during the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after buying an additional 126 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.
Insider Buying and Selling at Cigna Group
In related news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.
Cigna Group Price Performance
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter in the previous year, the firm earned $6.74 earnings per share. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities research analysts predict that Cigna Group will post 30.39 EPS for the current fiscal year.
Cigna Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a $1.56 dividend. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s payout ratio is currently 26.45%.
Analyst Ratings Changes
A number of brokerages have recently weighed in on CI. Guggenheim lifted their price target on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a report on Monday, May 4th. Truist Financial lifted their price target on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a report on Monday. UBS Group lifted their price target on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Finally, Robert W. Baird set a $337.00 price objective on Cigna Group in a research report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and an average target price of $338.30.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Read More
- Five stocks we like better than Cigna Group
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
